COVID-19 prophylaxis (excluding children) | |
first booster dose | C4591031- first boost C4591031- first boost |
mRNA vaccine (any) - first boost | |
Comirnaty - first boost | C4591031- first boost C4591031- first boost |
8345 | Pfizer/BioNTech Booster study, 2021 | 1 | 1 | 0 | risk of bias not avaialble | ||
8516 | Bar-On, 2021 | 1 | 11 | 0 | not a RCT | risk of bias not avaialble | |
9129 | COV-BOOST, 2021 | 2 | 1 | 0 | excluded | risk of bias not avaialble | |
9130 | Gilboa, 2021 | 2 | 0 | 0 | excluded | risk of bias not avaialble | |
9132 | Arbel, 2021 | 1 | 13 | 3 | not a RCT | high risk of bias | |
9173 | Sisonke 2 (booster), 2021 | 1 | 20 | 0 | not a RCT | risk of bias not avaialble | |
9174 | Barda, 2021 | 1 | 13 | 0 | not a RCT | risk of bias not avaialble | |
9175 | Patalon, 2021 | 1 | 20 | 0 | not a RCT | risk of bias not avaialble | |
9183 | Mattiuzzi, 2022 | 1 | 15 | 0 | not a RCT | risk of bias not avaialble | |
9203 | England (Andrews), 2021 | 1 | 20 | 0 | not a RCT | risk of bias not avaialble | |
9210 | Ontario (Buchan), 2022 | 1 | 20 | 0 | not a RCT | risk of bias not avaialble | |
9213 | COVI3, 2022 | 1 | 10 | 0 | not a RCT | risk of bias not avaialble | |
9275 | Mattiuzzi, 2022 | 2 | 0 | 0 | excluded | risk of bias not avaialble | |
9288 | Kislaya, 2022 | 1 | 11 | 0 | not a RCT | risk of bias not avaialble | |
9290 | Danza, 2022 | 2 | 32 | 0 | excluded | not a RCT | risk of bias not avaialble |
9293 | Tenforde, 2022 | 1 | 20 | 0 | not a RCT | risk of bias not avaialble | |
9331 | McConeghy, 2022 | 1 | 10 | 0 | not a RCT | risk of bias not avaialble | |
9411 | Accorsi, 2022 | 1 | 12 | 0 | not a RCT | risk of bias not avaialble | |
9415 | Patalon, 2022 | 1 | 20 | 0 | not a RCT | risk of bias not avaialble | |
9461 | Abu-Raddad, 2022 | 1 | 13 | 0 | not a RCT | risk of bias not avaialble |